A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet [sitagliptin/metformin ] Compared to Metformin.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Metformin/sitagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Jul 2011 Planned end date changed from Aug 2010 to Dec 2012 as reported by ClinicalTrials.gov.
- 12 Jun 2008 New trial record.